EE200200554A - Galantamiini või selle farmatseutiliselt sobiva soola kasutamine - Google Patents
Galantamiini või selle farmatseutiliselt sobiva soola kasutamineInfo
- Publication number
- EE200200554A EE200200554A EEP200200554A EEP200200554A EE200200554A EE 200200554 A EE200200554 A EE 200200554A EE P200200554 A EEP200200554 A EE P200200554A EE P200200554 A EEP200200554 A EE P200200554A EE 200200554 A EE200200554 A EE 200200554A
- Authority
- EE
- Estonia
- Prior art keywords
- galantamine
- pharmaceutically acceptable
- acceptable salt
- salt
- pharmaceutically
- Prior art date
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title 2
- 229960003980 galantamine Drugs 0.000 title 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19425900P | 2000-04-03 | 2000-04-03 | |
| PCT/EP2001/003553 WO2001074339A2 (en) | 2000-04-03 | 2001-03-28 | A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200554A true EE200200554A (et) | 2004-04-15 |
Family
ID=22716898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200554A EE200200554A (et) | 2000-04-03 | 2001-03-28 | Galantamiini või selle farmatseutiliselt sobiva soola kasutamine |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1272192A2 (et) |
| JP (1) | JP2003528913A (et) |
| KR (1) | KR20020086911A (et) |
| CN (1) | CN1430514A (et) |
| AU (2) | AU6584401A (et) |
| BG (1) | BG107093A (et) |
| BR (1) | BR0109770A (et) |
| CA (1) | CA2310926C (et) |
| CZ (1) | CZ20023543A3 (et) |
| EE (1) | EE200200554A (et) |
| HR (1) | HRP20020778A2 (et) |
| HU (1) | HUP0300566A3 (et) |
| IL (1) | IL152061A0 (et) |
| MX (1) | MXPA02009777A (et) |
| NO (1) | NO20024746L (et) |
| PL (1) | PL361272A1 (et) |
| RU (1) | RU2002129298A (et) |
| SK (1) | SK15422002A3 (et) |
| WO (1) | WO2001074339A2 (et) |
| ZA (1) | ZA200207935B (et) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6617361B2 (en) * | 1999-11-05 | 2003-09-09 | Be Able, Llc | Behavior chemotherapy |
| KR100764330B1 (ko) * | 2003-07-25 | 2007-10-05 | 에프. 호프만-라 로슈 아게 | 급성 및/또는 만성 신경학적 장애의 치료를 위한ｍＧｌｕＲ2 길항제 및 ＡＣｈＥ 억제제의 조합물 |
| DE10338544B4 (de) * | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
| EP4088717A1 (en) | 2008-03-27 | 2022-11-16 | Chase Pharmaceuticals Corporation | Use and composition for treating dementia |
| WO2013160728A1 (en) | 2012-04-26 | 2013-10-31 | Alma Mater Studiorum - Universita' Di Bologna | Dual targeting compounds for the treatment of alzheimer's disease |
| BG66818B1 (bg) * | 2013-03-07 | 2019-01-31 | Berbee Beheer B. V. | Състав на екстракт от hippeastrum papilio за производство на лекарствени средства и хранителни добавки |
| CN107847504A (zh) * | 2015-05-18 | 2018-03-27 | 斯奈普泰克发展有限责任公司 | 淀粉状蛋白β的加兰他敏清除 |
| CN117957003A (zh) * | 2021-09-09 | 2024-04-30 | 上海日馨医药科技股份有限公司 | 治疗神经退行性疾病的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| DE19509663A1 (de) * | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
| GB9600080D0 (en) * | 1996-01-04 | 1996-03-06 | Chiroscience Ltd | Resolution process |
| AU1738800A (en) | 1998-11-23 | 2000-06-13 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
| KR100437105B1 (ko) * | 1998-12-24 | 2004-06-23 | 얀센 파마슈티카 엔.브이. | 방출 조절형 갈란타민 조성물 |
| CA2310990A1 (en) * | 2000-04-03 | 2000-10-09 | Michael Pontecorvo | A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease |
| CA2310950C (en) * | 2000-04-03 | 2005-11-08 | Janssen Pharmaceutica N.V. | An efficacious dosage regiment of galantamine that reduces side effects |
-
2000
- 2000-06-27 CA CA002310926A patent/CA2310926C/en not_active Expired - Lifetime
-
2001
- 2001-03-28 HR HR20020778A patent/HRP20020778A2/xx not_active Application Discontinuation
- 2001-03-28 CZ CZ20023543A patent/CZ20023543A3/cs unknown
- 2001-03-28 CN CN01807334A patent/CN1430514A/zh active Pending
- 2001-03-28 JP JP2001572084A patent/JP2003528913A/ja not_active Withdrawn
- 2001-03-28 IL IL15206101A patent/IL152061A0/xx unknown
- 2001-03-28 AU AU6584401A patent/AU6584401A/xx active Pending
- 2001-03-28 BR BR0109770-9A patent/BR0109770A/pt not_active IP Right Cessation
- 2001-03-28 RU RU2002129298/14A patent/RU2002129298A/ru not_active Application Discontinuation
- 2001-03-28 PL PL36127201A patent/PL361272A1/xx not_active Application Discontinuation
- 2001-03-28 WO PCT/EP2001/003553 patent/WO2001074339A2/en not_active Ceased
- 2001-03-28 MX MXPA02009777A patent/MXPA02009777A/es unknown
- 2001-03-28 AU AU2001265844A patent/AU2001265844B2/en not_active Ceased
- 2001-03-28 KR KR1020027011063A patent/KR20020086911A/ko not_active Ceased
- 2001-03-28 EE EEP200200554A patent/EE200200554A/et unknown
- 2001-03-28 HU HU0300566A patent/HUP0300566A3/hu unknown
- 2001-03-28 SK SK1542-2002A patent/SK15422002A3/sk unknown
- 2001-03-28 EP EP01943200A patent/EP1272192A2/en not_active Withdrawn
-
2002
- 2002-09-12 BG BG107093A patent/BG107093A/bg unknown
- 2002-10-02 NO NO20024746A patent/NO20024746L/no not_active Application Discontinuation
- 2002-10-02 ZA ZA200207935A patent/ZA200207935B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6584401A (en) | 2001-10-15 |
| CA2310926A1 (en) | 2000-10-04 |
| SK15422002A3 (sk) | 2003-04-01 |
| IL152061A0 (en) | 2003-05-29 |
| NO20024746L (no) | 2002-11-28 |
| KR20020086911A (ko) | 2002-11-20 |
| NO20024746D0 (no) | 2002-10-02 |
| CZ20023543A3 (cs) | 2003-03-12 |
| CA2310926C (en) | 2002-10-15 |
| EP1272192A2 (en) | 2003-01-08 |
| AU2001265844B2 (en) | 2005-04-14 |
| HRP20020778A2 (en) | 2004-04-30 |
| CN1430514A (zh) | 2003-07-16 |
| WO2001074339A3 (en) | 2002-09-12 |
| BR0109770A (pt) | 2003-02-04 |
| HUP0300566A3 (en) | 2004-10-28 |
| PL361272A1 (en) | 2004-10-04 |
| MXPA02009777A (es) | 2003-03-27 |
| WO2001074339A2 (en) | 2001-10-11 |
| BG107093A (bg) | 2003-06-30 |
| JP2003528913A (ja) | 2003-09-30 |
| HUP0300566A2 (hu) | 2003-06-28 |
| ZA200207935B (en) | 2004-01-30 |
| RU2002129298A (ru) | 2004-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2020007I1 (no) | Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt | |
| NO2010007I1 (no) | Maraviroc eventuelt i form av et farmasøytisk akseptabelt salt | |
| DE60115555D1 (de) | Funduskamera | |
| NO2015026I2 (no) | panobinostat eller et farmasøytisk akseptabelt salt derav | |
| AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
| NO20030418L (no) | Nytt farmasöytisk preparat | |
| EP1296697A4 (en) | Therapeutic agents - i | |
| EP1253860A4 (en) | SURGICAL CLOSURE | |
| NO20030134L (no) | Fremstilling av olefinderivater | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| DE60106800D1 (de) | Funduskamera | |
| MA27126A1 (fr) | 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES | |
| DK1218374T3 (da) | Farmaceutisk aktive sulfonamidderivater | |
| DE60143985D1 (de) | Os | |
| ATE279238T1 (de) | Gewichtsmanschette | |
| FR2810231B1 (fr) | Cornee synthetique | |
| ATE348582T1 (de) | Kondom | |
| DE60128315D1 (de) | Funduskamera | |
| DE50103586D1 (de) | Fussheberorthese | |
| DE60112167D1 (de) | Vibrator | |
| EE200300434A (et) | Farmatseutiliselt toimivate ühendite kasutamine | |
| ID30381A (id) | Penggunaan arilalkanoilpiridazina | |
| SE0002922D0 (sv) | Pharmaceutically useful compounds | |
| SE0002921D0 (sv) | Pharmaceutically useful compounds | |
| SE0004458D0 (sv) | Pharmaceutically useful compounds |